1. Alessandri B, Rice AC, Levasseur J, DeFord M, Hamm RJ, Bullock MR.
Cyclosporin
A improves brain tissue oxygen consumption and learning/memory performance
after lateral fluid percussion injury in rats. J Neurotrauma.
2002;Jul;19(7):829-41.
2. Riess P, Bareyre FM, Saatman KE, Cheney JA, Lifshitz J, Raghupathi
R, Grady MS, Neugebauer E, McIntosh TK. Effects
of chronic, post-injury Cyclosporin A administration on motor and sensorimotor
function following severe, experimental traumatic brain injury.
Restor Neurol Neurosci. 2001;18(1):1-8.
3.Vink R, Nimmo AJ, Cernak I. An
overview of new and novel pharmacotherapies for use in traumatic brain
injury. Clin Exp Pharmacol Physiol. 2001;Nov;28(11):919-21.
4. Clausen T, Bullock R. Medical
treatment and neuroprotection in traumatic brain injury.
Curr Pharm Des. 2001;Oct;7(15):1517-32.
5. Albensi BC, Sullivan PG, Thompson MB, Scheff SW, Mattson MP. Cyclosporin
ameliorates traumatic brain-injury-induced alterations of hippocampal
synaptic plasticity. Exp Neurol 2000;162(2):385-9.
6. Gold BG. Neuroimmunophilin
ligands: evaluation of their therapeutic potential for the treatment
of neurological disorders. Expert Opin Investig Drugs 2000;9(10):2331-42.
7. Sullivan PG, Rabchevsky AG, Hicks RR, Gibson TR, Fletcher-Turner
A, Scheff SW. Dose-response
curve and optimal dosing regimen of cyclosporin A after traumatic brain
injury in rats. Neuroscience 2000;101(2):289-95.
8. Scheff SW, Sullivan PG. Cyclosporin
A significantly ameliorates cortical damage following experimental traumatic
brain injury in rodents. J. Neurotrauma 1999;16(9):783-92.
9. Sullivan PG, Thompson MB, Scheff SW. Cyclosporin
A attenuates acute mitochondrial dysfunction following traumatic brain
injury. Exp. Neurol. 1999;160(1):226-34.
10. Sullivan PG, Thompson M, Scheff SW. Continuous
Infusion of Cyclosporin A Postinjury Significantly Ameliorates Cortical
Damage Following Traumatic Brain Injury. Exp Neurol 2000;
161:631-637.
11. Buki A, Okonkwo DO, Povlishock JT. Postinjury
cyclosporin A administration limits axonal damage and disconnection
in traumatic brain injury. J Neurotrauma 1999;16(6):511-21.
12. Diaz-Ruiz A, Rios C, Duarte I, et al. Cyclosporin-A
inhibits lipid peroxidation after spinal cord injury in rats. Neurosci
Lett 1999;266(1):61-4.
13. Morioka M, Hamada J, Ushio Y, Miyamoto E. Potential
role of calcineurin for brain ischemia and traumatic injury. Prog
Neurobiol 1999;58(1):1-30.
14. Okonkwo DO, Buki A, Siman R, Povlishock JT. Cyclosporin
A limits calcium-induced axonal damage following traumatic brain injury.
Neuroreport 1999;10(2):353-8.
15. Okonkwo DO, Povlishock JT. An
intrathecal bolus of cyclosporin A before injury preserves mitochondrial
integrity and attenuates axonal disruption in traumatic brain injury.
J Cereb Blood Flow Metab 1999;19(4):443-451.
16. Gogarten W, Van Aken H, Moskopp D, et al. A
case of severe cerebral trauma in a patient under chronic treatment
with cyclosporine A. J Neurosurg Anesthesiol 1998;10(2):101-5.
17. Gold BG. FK506
and the role of immunophilins in nerve regeneration.
Mol Neurobiol 1997;15(3):285-306.
18. Gold BG, Zeleny-Pooley M, Wang MS, Chaturvedi P, Armistead DM. A
nonimmunosuppressant FKBP-12 ligand increases nerve regeneration.
Exp Neurol 1997;147(2):269-78.